Do HIV-positive women receive depression treatment that meets best practice guidelines?

AIDS and Behavior

Volumn 18, Issue 6, 2014, Pages 1094-1102

  Cook, Judith A ^a   Burke Miller, Jane K ^b   Grey, Dennis D ^a   Cocohoba, Jennifer ^c   Liu, Chenlong ^d   Schwartz, Rebecca M ^e   Golub, Elizabeth T ^f   Anastos, Kathryn ^g   Steigman, Pamela J ^a   Cohen, Mardge H ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b HEKTOEN INSTITUTE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

^e DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Depression treatment; Psychopharmacology; Psychotherapy; Women and HIV

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIDEPRESSANT AGENT;

ADULT; AFRICAN AMERICAN; CAUCASIAN; COMPLICATION; DEPRESSION; ETHNOLOGY; FEMALE; HEALTH CARE DISPARITY; HEALTH CARE PERSONNEL; HISPANIC; HIV SEROPOSITIVITY; HUMAN; MEDICATION COMPLIANCE; MIDDLE AGED; NEEDS ASSESSMENT; PREVALENCE; QUALITY CONTROL; SELF REPORT; STATISTICS AND NUMERICAL DATA; UNITED STATES; WOMEN'S HEALTH;

ADULT; AFRICAN AMERICANS; ANTI-HIV AGENTS; ANTIDEPRESSIVE AGENTS; BENCHMARKING; DEPRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH PERSONNEL; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HIV SEROPOSITIVITY; HUMANS; MEDICATION ADHERENCE; MIDDLE AGED; NEEDS ASSESSMENT; PREVALENCE; SELF REPORT; UNITED STATES; WOMEN'S HEALTH;

EID: 84905577511     PISSN: 10907165     EISSN: 15733254     Source Type: Journal    
DOI: 10.1007/s10461-013-0679-6     Document Type: Article

References (62)

1. Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV epidemiology research study. JAMA. 2001;285:1466-74.
2. Cook JA, Grey DD, Burke-Miller JK, Cohen MH, Vlahov D, Kapadia F, Wilson TE, Cook R, Schwartz RM, Golub ET, Anastos K, Ponath C, Goparaju L, Levine AM. Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women. Drug Alcohol Depend. 2007;89:74-81.
3. Cook JA, Cohen MH, Burke J, Grey DD, Anastos K, Kirstein L, Palacio H, Richardson J, Wilson T, Young M. Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women. J Acquir Immune Defic Syndr. 2002;30:401-9.
4. Agency for Healthcare Policy and Research. Depression in primary care, Vol 2: treatment of major depression. Rockville: US Department of Health and Human Services; 1993.
5. American Psychiatric Association. Practice guideline for treatment of patients with major depressive disorder. 2nd ed. Washington, DC: American Psychiatric Association Press; 2000.
6. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095-105.
7. Young AS, Klap R, Sherbourne CD, Wells KB. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry. 2001;58:55-61.
8. Wang PS, Berglund P, Kessler RC. Recent care of common mental disorders in the United States: prevalence and conformance with evidence-based recommendations. J Gen Intern Med. 2000;15:264-92.
9. Sambamoorthi U, Walkup J, Olfson M, Crystal S. Antidepressant treatment and health services utilization among HIV-infected medicaid patients diagnosed with depression. Int J Gen Med. 2000;15(5):311-20.
10. Burnam MA, Bing EG, Morton SC, Sherbourne C, Fleishman JA, London AS, Vitiello B, Stein M, Bozette SA, Shapiro MF. Use of mental health and substance abuse treatment services among adults with HIV in the United States. Arch Gen Psychiatry. 2001;58:729-36.
11. Yun WHI, Maravi M, Kobayashi JS, Barton PL, Davidson AJ. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr. 2005;38(4):432-8.
12. Hall HI, Geduld J, Boulos D, Rhodes P, An Q, Mastro T, Janssen RS, Archibald CP. Epidemiology of HIV in the United States and Canada: current status and ongoing challenges. J Acquir Immune Defic Syndr. 2009;51:S13-20.
13. Alegria M, Chatterji P, Wells K, Cao Z, Chen C, Takeuchi D, Jackson J, Meng X. Disparity in depression treatment among racial and ethnic minority populations in the United States. Psychiatr Serv. 2008;59:1264-72.
14. Givens JL, Houston TK, Van Voorhees BWV, Ford DE, Cooper LA. Ethnicity and preferences for depression treatment. Gen Hosp Psychiatry. 2007;29:182-91.
15. Harman JS, Edlund MJ, Fortney JC. Disparities in the adequacy of depression treatment in the United States. Psychiatr Serv. 2004;55:1379-85.
16. Sturm R, Meredith LA, Wells KB. Provider choice and continuity for the treatment of depression. Med Care. 1996;34(7):723-34.
17. Druss BG, Rask K, Katon WJ. Major depression, depression treatment, and quality of primary medical care. Gen Hosp Psychiatry. 2008;30(1):20-5.
18. Simon GE, Fleck M, Bushnell DM. Prevalence and predictors of depression treatment in an international primary care study. Am J Psychiatry. 2004;161(9):1626-34.
19. Harman JS, Kelleher KJ, Reynolds CF, Pincus HA. Out-of-pocket healthcare expenditures of older Americans with depression. J Am Geriatr Soc. 2004;52(1):809-13.
20. Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36:1-10.
21. Anthony MN, Gardner L, Marks G, Anderson-Mahoney P, Metsch LR, Valverde EE, del Rios C, Loughlin AM. Factors associated with use of HIV primary care among persons recently diagnosed with HIV: examination of variables from the behavioural model of health-care utilization. AIDS Care. 2007;19(2):195-202.
22. Dobalian A, Andersen RM, Stein JA, Hays RD, Cunningham WE, Marcus M. The impact of HIV on oral health and subsequent use of dental services. J Public Health Dent. 2003;63(2):78-85.
23. Scheppers E, van Dongen E, Dekker J, Geertzen J, Dekker J. Potential barriers to the use of health services among ethnic minorities: a review. Fam Pract. 2006;23(3):325-38.
24. Barkan SE, Melnick SL, Preston-Martin S, et al. The Women's Interagency HIV Study. Epidemiology. 1998;9:117-25.
25. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.
26. Low-Beer S, Chan K, Yip B, et al. Depressive symptoms decline among persons on HIV protease inhibitors. J Acquir Immune Defic Syndr. 2000;23:295-301.
27. Naughton MJ, Wiklund I. A critical review of dimension-specific measures of health-related quality of life in cross-cultural research. Qual Life Res. 1993;2(6):397-432.
28. Roberts RE. Reliability of the CES-D scale in different ethnic contexts. Psychiatry Res. 1980;2(2):125-34.
29. Fechner-Bates S, Coyne JC, Schwenk TL. The relationship of self-reported distress to depressive disorders and other psychopathology. J Consult Clin Psychol. 1994;62(3):550-9.
30. Breslau N. Depressive symptoms, major depression, and generalized anxiety: a comparison of self-reports on CES-D and results from diagnostic interviews. Psychiatry Res. 1985;15(3): 219-29.
31. Kessler RC, Üstun TB. The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) composite international diagnostic interview (CIDI). Int J Methods Psychiatr Res. 2004;13(2):93-212.
32. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author; 2000.
33. Kessler RC, Abelson J, Demler O, Escobar JI, Gibbon M, Guyer ME, Howes MJ, Jin R, Vega WA, Walters EE, Wang P, Zaslavsky A, Zheng H. Clinical calibration of DSM-IV diagnoses in the World Mental Health (WMH) version of the World Health Organization (WHO) composite international diagnostic interview (CIDI). Int J Methods Psychiatr Res. 2004;13(2):122-39.
34. Haro JM, Arbabzadeh-Bouchez S, Brugha TS, de Girolamo G, Guyer ME, Jin R, Lepine J-P, Mazzi F, Reneses B, Vilagut G, Sampson NA, Kessler RC. Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health Surveys. Int J Methods Psychiatr Res. 2006;15(4):167-80.
35. Carpenter C, Hidalgo J, Jaffe H, Feinberg N, et al. Report of the NIH panel to define principles of therapy of HIV infection. MMWR Morb Mortal Wkly Rep. 1998;47:1-41.
36. Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-33.
37. Han C, Pulling CC, Telke SE, Huppler Hullsiek K. Assessing the utility of five domains in SF-12 health status questionnaire in an AIDS clinical trial. AIDS. 2002;16:431-9.
38. Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York: Wiley; 2000.
39. Kendler K. Is seeking treatment for depression predicted by a history of depression in relatives? Implications for family studies of affective disorder. Psychol Med. 1995;25:807-14.
40. Blumenthal R, Endicott J. Barriers to seeking treatment for major depression. Depress Anxiety. 1996;4(6):273-8.
41. Hampton T. HIV study shines spotlight on women. JAMA. 2010;304(3):257-8.
42. Cohen MH. Women and HIV: creating an ambience of caring. J Am Med Women Assoc. 2001;56(1):9-10.
43. Druss BG, Marcus SC, Olfson M, Tanielian T, Elinson L, Pincus HA. Comparing the national economic burden of five chronic conditions. Health Aff. 2001;20(6):233-41.
44. Freudenreich O, Goforthe HW, Cozza KL, Mimiaga MJ, Safren SA, Bachmann G, Cohen MA. Psychiatric treatment of persons with HIV/AIDS: an HIV-psychiatry consensus survey of current practices. Psychosomatics. 2010;51(6):480-8.
45. Kautz C, Mauch D, Smith SA. Reimbursement of mental health services in primary care settings (HHS Pub. No. SMA-08-4324). Rockville, MD: Center for Mental Health Services, Substance Abuse and Mental Health Services Administration; 2008.
46. Katon W, Von Korff M, Lin E, Simon GE. Rethinking practitioner roles in chronic illness: the specialist primary care physician and the practice nurse. Gen Hosp Psychiatry. 2001;23:138-44.
47. Simon G. Collaborative care for depression. BMJ. 2006;332: 249-50.
48. Gilbody S, Bower P, Fletcher J, Richards D, Sutton AJ. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med. 2006;166: 2314-21.
49. Cheever LW, Kresina TF, Cajina A, Lubran R. A model federal collaborative to increase patient access to buprenorphine treatment in HIV primary care. J Acquir Immune Defic Syndr. 2011;56:S3-6.
50. Cooper LA, Gonzales J, Gallo JJ, Rost KM, Meredith LS, Rubenstein LV, Wang NY, Ford DE. The acceptability of treatment for depression among African-American, Hispanic, and White primary care patients. Med Care. 2003;41(4):479-89.
51. Goldberg DP, Lecrubier Y. Form and frequency of mental disorders across centres. In: Form TB, Sartorius N, editors. Mental illness in general health care. An international study. Chichester: Wiley; 1995. p. 323-34.
52. Weissman MM, Bland RC, Canino GJ, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA. 1996;276(4):293-9.
53. Abas MA, Phillips C, Carter J, Walter J, et al. Culturally sensitive validation of screening questionnaires for depression in older African-Caribbean people living in south London. Br J Psychiatr. 1998;173:249-54.
54. Delgado PL, Alegria M, Canive JM, Diaz E, et al. Depression and access to treatment among U.S. Hispanics: review of the literature and recommendations for policy and research. Focus. 2006;4(1):38-47.
55. Johnson SD, Cunningham-Williams RM, Cottler LB. A tripartite of HIV-risk for African American women: the intersection of drug use, violence, and depression. Drug Alcohol Depend. 2003;70:169-75.
56. Miranda J, Chung JY, Green BL, Krupnick J, Siddique J, Revicki DA, Belin T. Treating depression in predominantly low-income young minority women: a randomized controlled trial. JAMA. 2003;290(1):57-65.
57. Stein MD, Solomon DA, Herman DS, Anthony JL, et al. Pharmacotherapy plus psychotherapy for treatment of depression in active injection drug users. Arch Gen Psychiatr. 2004;61:152-9.
58. Paykel ES, Priest RG. Recognition and management of depression in general practice: consensus statement. BMJ. 1992;305: 1198.
59. El-Khorazaty MN, Johnson AA, Kiely M, El-Mohandes AAE, Subramanian S, Laryea HA, Murray KB, Thornberry JS, Joseph JG. Recruitment and retention of low-income minority women in a behavioral intervention to reduce smoking, depression, and intimate partner violence during pregnancy. BMC Public Health. 2007;7:233-48.
60. Cook JA, Grey D, Burke J, Cohen MH, Gurtman AC, Richardson JL, Wilson TE, Young MA, Hessol NA. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIVpositive women. Am J Public Health. 2004;94(7):1133-40.
61. Von Korff M, Katon W, Bush T, Lin EH, Simon GE, Saunders K, Ludman E, Walker E, Unutzer J. Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression. Psychosom Med. 1998;60:143-9.
62. Strain JJ, Lyons JS, Hammer JS, Fahs M, Lebovits A, Paddison PL, Snyder S, Strauss E, Burton R, Nuber G, et al. Cost offset from a psychiatric consultation-liaison intervention with elderly hip fracture patients. Am J Psychiatry. 1991;148:1044-9.